EMCURE - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:02 am

IntraDay Trade Rating: 3.5

📊 Analysis: EMCURE is trading at ₹1,383, exactly at its 50 DMA (₹1,383) and above the 200 DMA (₹1,332), showing medium-term support. RSI at 49.2 indicates neutral momentum, while MACD (5.76) reflects mild bullish bias. Intraday volume (35,654) is significantly below average (81,584), suggesting weak participation. The stock is closer to its 52-week high (₹1,525) than its low (₹889), reflecting strength but also resistance near upper levels.

• 💡 Optimal Buy Price: ₹1,375–₹1,385 range if support near ₹1,370 holds.
• 📈 Profit-Taking Exit Levels: ₹1,400 (minor resistance), ₹1,420–₹1,440 (short-term resistance zone).
• ⚠️ Stop-Loss / Loss Protection: ₹1,365 (below intraday support).
• ⏱️ If Already Holding: Consider exiting near ₹1,400–₹1,440 if momentum stalls; cut positions if price breaks below ₹1,365 with rising volume.

Positive

• 📌 EPS at ₹22.7 provides earnings base.
• 📌 PAT at ₹118 Cr. remains strong despite slight decline.
• 📌 ROCE (13.5%) and ROE (11.6%) show moderate efficiency.
• 📌 DII holding increased by 1.52% — domestic institutions showing confidence.
• 📌 FII holding increased by 0.43% — foreign investors adding exposure.

Limitation

• ⚠️ Current price at 50 DMA but low volume — weak intraday conviction.
• ⚠️ PEG ratio (-4.47) indicates poor growth relative to valuation.
• ⚠️ Debt-to-equity ratio at 0.50 — moderate leverage risk.
• ⚠️ High P/E (60.6 vs industry 30.6) — premium valuation.

Company Negative News

• ❌ Quarterly PAT declined from ₹125 Cr. to ₹118 Cr. (-5.6%).
• ❌ Weak intraday volume compared to average participation.

Company Positive News

• ✅ EPS and ROCE/ROE support fundamentals.
• ✅ Institutional confidence reflected in increased DII and FII holdings.
• ✅ PAT remains stable despite minor decline.

Industry

• 🏦 Industry P/E at 30.6 — sector moderately valued.
• 🏦 EMCURE trades at a steep premium (P/E 60.6), reflecting growth optimism but valuation risk.

Conclusion

⚖️ EMCURE is a moderate intraday candidate today with neutral RSI and mild bullish MACD. Traders may attempt entries near ₹1,375–₹1,385 with stop-loss at ₹1,365 and aim for exits between ₹1,400–₹1,440. Fundamentals remain supportive, but low intraday volume and stretched valuation suggest cautious scalping rather than aggressive intraday trades.

Would you like me to extend this into a pharma & biotech sector basket overlay so you can benchmark EMCURE against peers like Biocon, Laurus Labs, and Divis Labs for intraday rotation setups?